KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Net Margin (2016 - 2025)

Eli Lilly's Net Margin history spans 16 years, with the latest figure at 34.41% for Q4 2025.

  • For Q4 2025, Net Margin rose 182.0% year-over-year to 34.41%; the TTM value through Dec 2025 reached 31.67%, up 816.0%, while the annual FY2025 figure was 31.67%, 816.0% up from the prior year.
  • Net Margin reached 34.41% in Q4 2025 per LLY's latest filing, up from 31.72% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 36.38% in Q2 2025 to a low of 0.6% in Q3 2023.
  • Average Net Margin over 5 years is 22.27%, with a median of 21.63% recorded in 2021.
  • Peak YoY movement for Net Margin: plummeted -2152bps in 2023, then soared 2323bps in 2025.
  • A 5-year view of Net Margin shows it stood at 21.58% in 2021, then grew by 23bps to 26.54% in 2022, then fell by -12bps to 23.41% in 2023, then soared by 39bps to 32.59% in 2024, then rose by 6bps to 34.41% in 2025.
  • Per Business Quant, the three most recent readings for LLY's Net Margin are 34.41% (Q4 2025), 31.72% (Q3 2025), and 36.38% (Q2 2025).